Pharmacotherapy for Primary CNS Lymphoma: Progress Beyond Methotrexate?

ISSN： 1172-7047

Source： CNS Drugs, Vol.25, Iss.6, 2011-06, pp. : 447-457

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lymphoma in Patients with Rheumatoid Arthritis: What is the Evidence of a Link with Methotrexate?

By Georgescu L. Paget S.A.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 475-487

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of primary CNS lymphoma

By Park Deric Minwoo Abrey Lauren E

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 39-49

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy or Surgery as Primary Treatment for Acromegaly?

By Ferone D.

Drugs & Aging, Vol. 17, Iss. 2, 2000-08 ,pp. : 81-92

Adis International

Access to resources Recommend Favorite

Rituximab plus methotrexate-based chemotherapy (R-MPV) and whole-brain radiotherapy (WBRT) is promising for primary CNS lymphoma

Inpharma, Vol. 1, Iss. 1613, 2007-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for Cannabis Dependence: How Close Are We?

By Vandrey Ryan

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 543-553

Adis International

Access to resources Recommend Favorite